New diabetes clinical trial: HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
- Get link
- X
- Other Apps
Published on: September 25, 2020 at 09:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: HSK7653 10 mg Q2W; Drug: HSK7653 25 mg Q2W; Drug: Linagliptin 5 mg QD
Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd.
Not yet recruiting
https://ift.tt/3mLmxAl
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: HSK7653 10 mg Q2W; Drug: HSK7653 25 mg Q2W; Drug: Linagliptin 5 mg QD
Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd.
Not yet recruiting
https://ift.tt/3mLmxAl
Comments
Post a Comment